CANARIABIO Inc. Stock Price

KOSDAQ:A016790 Community·₩187.3b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

A016790 Share Price Performance

₩0

0.00 (0.00%)

₩0

0.00 (0.00%)

₩0

Tue, 2 Dec 25

Share Pricen/a

A016790 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Weak fundamentals or lack of information.

4 Risks

1 Reward

View Full Analysis

CANARIABIO Inc. Key Details

Last Reported Earnings

Dec 31, 2023

Next Reporting Earnings

n/a

: -1.11k
: 14.06%
: -129.72%
: -221.4%

View Full Analysis

About A016790

Founded: 1983
Employees: 78
CEO: n/a
WebsiteView website: www.canariabio.com

CANARIABIO Inc. engages in the manufacture and sale of formulated feed. Its primary products include poultry and pig feed. The company also engages in the biopharmaceutical business. In addition, it focuses on the development and commercialization of immunotherapies for cancer. Further, the company’s lead product includes oregovomab, an immunotherapy for ovarian cancer. Additionally, it is involved in the developing AR20.5, which treatment of pancreatic cancer. The company was founded in 1983 and is headquartered in Seoul, South Korea.